PARIS--(BUSINESS WIRE)--Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways. Drug-Drug interactions (DDIs) are a major concern in the pharmaceutical industry today. DDIs have led to several
For more information, please visit
http://www.businesswire.com/news/home/20090917005392/en